PARP9 and neoplasm: As seen in Figure 6, PARP9 had a high concordance with prominent immune checkpoint molecules, including PD‐1, PD‐L1, B7‐H3, and TIM‐3, suggesting their synergistic roles in regulating the immune response within the tumor microenvironment.